BACKGROUND AND AIM: Since using LDL level alone is insufficient as a method to identify individuals with incident coronary artery disease (CAD), other factors may be implicated in the pathogenesis of CAD. Additionally, controversy still remains regarding whether there is an age-related increase in circulating cytokines in healthy individuals. We investigated the influence of age on atherogenicity of LDL and inflammatory markers in healthy women. METHODS AND RESULTS: Two thousand nine hundred forty four healthy women form 30-79 years old (23.3 ± 0.05 kg/m²) were categorized into 5 age groups: 30-39, 40-49, 50-59, 60-69 and 70-79 years. BMI, smoking, drinking, and metabolic syndrome prevalence adjusted mean values of total-cholesterol progressively increased from the group age 30-39 years to the group age 40-49 and 50-59 years and thereafter decreased in the group age 60-69 and 70-79 years. Serum concentrations of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were higher in women aged 60-79 years than women aged 30-59 years. Plasma ox-LDL levels increased in the group age 50-59 years compared with the group age 30-39 and 40-49 years and further increased in the group age 60-69 and 70-79 years. Mean values of LDL particle size were smaller in women aged 60-79 years than those in women aged 30-59 years. After adjustment for BMI, smoking, drinking, and metabolic syndrome status, age was positively correlated with LDL-cholesterol (r = 0.095, P < 0.001), oxidized LDL (r = 0.305, P < 0.001), hs-CRP (r = 0.150, P < 0.001), TNF-α (r = 0.171, P < 0.001) and IL-6 (r = 0.294, P < 0.001) and negatively with LDL particle size (r = -0.239, P < 0.001). CONCLUSION: Our results indicate that LDL atherogenicity and inflammatory mediators can be better markers of CAD risk than known risk factors such as elevated concentrations of total- and LDL-cholesterol, decreased HDL-cholesterol levels and smoking in old healthy women.
BACKGROUND AND AIM: Since using LDL level alone is insufficient as a method to identify individuals with incident coronary artery disease (CAD), other factors may be implicated in the pathogenesis of CAD. Additionally, controversy still remains regarding whether there is an age-related increase in circulating cytokines in healthy individuals. We investigated the influence of age on atherogenicity of LDL and inflammatory markers in healthy women. METHODS AND RESULTS: Two thousand nine hundred forty four healthy women form 30-79 years old (23.3 ± 0.05 kg/m²) were categorized into 5 age groups: 30-39, 40-49, 50-59, 60-69 and 70-79 years. BMI, smoking, drinking, and metabolic syndrome prevalence adjusted mean values of total-cholesterol progressively increased from the group age 30-39 years to the group age 40-49 and 50-59 years and thereafter decreased in the group age 60-69 and 70-79 years. Serum concentrations of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were higher in women aged 60-79 years than women aged 30-59 years. Plasma ox-LDL levels increased in the group age 50-59 years compared with the group age 30-39 and 40-49 years and further increased in the group age 60-69 and 70-79 years. Mean values of LDL particle size were smaller in women aged 60-79 years than those in women aged 30-59 years. After adjustment for BMI, smoking, drinking, and metabolic syndrome status, age was positively correlated with LDL-cholesterol (r = 0.095, P < 0.001), oxidized LDL (r = 0.305, P < 0.001), hs-CRP (r = 0.150, P < 0.001), TNF-α (r = 0.171, P < 0.001) and IL-6 (r = 0.294, P < 0.001) and negatively with LDL particle size (r = -0.239, P < 0.001). CONCLUSION: Our results indicate that LDL atherogenicity and inflammatory mediators can be better markers of CAD risk than known risk factors such as elevated concentrations of total- and LDL-cholesterol, decreased HDL-cholesterol levels and smoking in old healthy women.
Authors: Dominique Piber; Richard Olmstead; Joshua Hyong-Jin Cho; Tuff Witarama; Christian Perez; Nicholas Dietz; Teresa E Seeman; Elizabeth C Breen; Steve W Cole; Michael R Irwin Journal: J Gerontol A Biol Sci Med Sci Date: 2019-10-04 Impact factor: 6.053
Authors: Dong Hee Lee; Minkyung Kim; Minjoo Kim; Young Ju Lee; Hye Jin Yoo; Sang-Hyun Lee; Jong Ho Lee Journal: Immunol Res Date: 2017-10 Impact factor: 2.829
Authors: John T Petroff; Ankita Isor; Satyanarayana M Chintala; Carolyn J Albert; Jacob D Franke; David Weinstein; Sara M Omlid; Christopher K Arnatt; David A Ford; Ryan D McCulla Journal: RSC Adv Date: 2020-07-15 Impact factor: 4.036
Authors: Joana A Dias; Gunilla N Fredrikson; Ulrika Ericson; Bo Gullberg; Bo Hedblad; Gunnar Engström; Signe Borgquist; Jan Nilsson; Elisabet Wirfält Journal: PLoS One Date: 2016-07-08 Impact factor: 3.240
Authors: Sylvia E Badon; Kelley Pettee Gabriel; Carrie Karvonen-Gutierrez; Barbara Sternfeld; Ellen B Gold; L Elaine Waetjen; Catherine Lee; Lyndsay A Avalos; Samar R El Khoudary; Monique M Hedderson Journal: Maturitas Date: 2021-02-06 Impact factor: 4.342
Authors: M Moreno-Villanueva; J Morath; V Vanhooren; T Elbert; S Kolassa; C Libert; A Bürkle; I-T Kolassa Journal: Transl Psychiatry Date: 2013-10-29 Impact factor: 6.222